Diffusion-weighted imaging in addition to contrast-enhanced MRI in identifying complete response in HER2-positive breast cancer
European Radiology · 2024
DOI: 10.1007/s00330-024-10857-7 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Radiology, 2024. Verfasst von Anna van der Voort und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. a.vd.voort@nki.nl. Hauptthemen laut MEDLINE: Breast Neoplasms, Diffusion Magnetic Resonance Imaging, Contrast Media, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
The aim of this study is to investigate the added value of diffusion-weighted imaging (DWI) to dynamic-contrast enhanced (DCE)-MRI to identify a pathological complete response (pCR) in patients with HER2-positive breast cancer and radiological complete response (rCR). Materials and methods This is a single-center observational study of 102 patients with stage I-III HER2-positive breast cancer and real-world documented rCR on DCE-MRI. Patients were treated between 2015 and 2019. Both 1.5 T/3.0 T single-shot diffusion-weighted echo-planar sequence were used. Post neoadjuvant systemic treatment (NST) diffusion-weighted images were reviewed by two readers for visual evaluation and ADCmean. Discordant cases were resolved in a consensus meeting. pCR of the breast (ypT0/is) was used to calculate the negative predictive value (NPV). Breast pCR-percentages were tested with Fisher’s exact test. ADCmean and ∆ADCmean(%) for patients with and without pCR were compared using a Mann-Whitney U-test.
Results
The NPV for DWI added to DCE is 86% compared to 87% for DCE alone in hormone receptor (HR)-/HER2-positive and 67% compared to 64% in HR-positive/HER2-positive breast cancer. Twenty-seven of 39 non-rCR DWI cases were false positives. In HR-positive/HER2-positive breast cancer the NPV for DCE MRI differs between MRI field strength (1.5 T: 50% vs. 3 T: 81% [ p = 0.02]). ADCmean at baseline, post-NST, and ∆ADCmean were similar between patients with and without pCR.
Conclusion
DWI has no clinically relevant effect on the NPV of DCE alone to identify a pCR in early HER2-positive breast cancer. The added value of DWI in HR-positive/HER2-positive breast cancer should be further investigated taken MRI field strength into account. Clinical relevance statement The residual signal on DWI after neoadjuvant systemic therapy in cases with early HER2-positive breast cancer and no residual pathologic enhancement on DCE-MRI breast should not (yet) be considered in assessing a complete radiologic response. Key Points Radiologic complete response is associated with a pathologic complete response (pCR) in HER2+ breast cancer but further improvement is warranted. No relevant increase in negative predictive value was observed when DWI was added to DCE. Residual signal on DW-images without pathologic enhancement on DCE-MRI, does not indicate a lower chance of pCR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. a.vd.voort@nki.nl.
- Department of Radiology, the Netherlands Cancer Institute, Amsterdam, The Netherlands.
- GROW School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, The Netherlands.
- Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.
- Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
- Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, The Netherlands.
Zitieren
APA
van der Voort, A., van der Hoogt, K. J. J., Wessels, R., Schipper, R. J., Wesseling, J., Sonke, G. S., & Mann, R. M. (2024). Diffusion-weighted imaging in addition to contrast-enhanced MRI in identifying complete response in HER2-positive breast cancer. European Radiology. https://doi.org/10.1007/s00330-024-10857-7
Vancouver
van der Voort A, van der Hoogt KJJ, Wessels R, Schipper RJ, Wesseling J, Sonke GS, et al. Diffusion-weighted imaging in addition to contrast-enhanced MRI in identifying complete response in HER2-positive breast cancer. European Radiology. 2024. doi:10.1007/s00330-024-10857-7
BibTeX
@article{vanderVoort2024,
author = {van der Voort, Anna and van der Hoogt, Kay J J and Wessels, Ronni and Schipper, Robert-Jan and Wesseling, Jelle and Sonke, Gabe S and Mann, Ritse M},
title = {Diffusion-weighted imaging in addition to contrast-enhanced MRI in identifying complete response in HER2-positive breast cancer},
journal = {European Radiology},
year = {2024},
doi = {10.1007/s00330-024-10857-7}
}
EUVIMED